Cancer and the Risk of Blood Clots
https://libcat.nshealth.ca/en/permalink/chpams37420
Nova Scotia Health. Cancer Care Program.
[Halifax, NS]:
Nova Scotia Cancer Care Program
, 2018.
- Pamphlet Number
- 1675
- Available Online
- View Pamphlet
Cancer patients may be more at risk of developing blood clots, also called Cancer Associated Thrombosis or CAT. This pamphlet describes what blood clots are, those at highest risk, and what conditions may come from CAT. Terms used in the guide are explained.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Cancer Care Program
- Place of Publication
- [Halifax, NS]
- Publisher
- Nova Scotia Cancer Care Program
- Date of Publication
- 2018
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Blood Coagulation Disorders
- Neoplasms - complications
- Subjects (LCSH)
- Blood coagulation disorders
- Cancer--Complications
- Specialty
- Hematology
- Abstract
- Cancer patients may be more at risk of developing blood clots, also called Cancer Associated Thrombosis or CAT. This pamphlet describes what blood clots are, those at highest risk, and what conditions may come from CAT. Terms used in the guide are explained.
- Notes
- Patient & family guide
- Responsibility
- prepared by Nova Scotia Cancer Care Program
- Pamphlet Number
- 1675
Dalteparin (Fragmin) to prevent clotting during hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 1760
- Available Online
- View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Dalteparin
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Blood--coagulation
- Specialty
- Nephrology
- Abstract
- Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1760
Factor product pick-up
https://libcat.nshealth.ca/en/permalink/chpams35504
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Program, IWK Health Centre. Pediatric Bleeding Disorder Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0928
- Available Online
- View Pamphlet
If you have a hereditary bleeding disorder and infuse factor products at home, this pamphlet will be given to you with instructions for when and where you can pick up products. Information on prescriptions and infusion records is also provided.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Program
- IWK Health Centre. Pediatric Bleeding Disorder Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([6] p.) : digital, PDF file
- Subjects (MeSH)
- Blood Coagulation Disorders, Inherited
- Hematologic Diseases
- Subjects (LCSH)
- Blood coagulation disorders
- Specialty
- Hematology
- Abstract
- If you have a hereditary bleeding disorder and infuse factor products at home, this pamphlet will be given to you with instructions for when and where you can pick up products. Information on prescriptions and infusion records is also provided.
- Responsibility
- Prepared by: Nova Scotia Provincial Blood Coordinating Program, QE II, Adult Bleeding Disorder Clinic, and IWK Pediatric Bleeding Disorder Clinic
- Pamphlet Number
- 0928
Low Platelets : Thrombocytopenia
https://libcat.nshealth.ca/en/permalink/chpams37360
Nova Scotia Health. Cancer Care Program.
[Halifax, NS]:
Nova Scotia Cancer Care Program
, 2018.
- Pamphlet Number
- 0032
- Available Online
- View Pamphlet
Platelets (PLT), thrombocytes, are blood cells that helps it to clot (stop bleeding). Not having enough platelets in your blood is called thrombocytopenia (throm·bo·cy·to·pe·nia). This pamphlets describes what causes low platelets, symptoms, and ways to prevent and manage it.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Cancer Care Program
- Place of Publication
- [Halifax, NS]
- Publisher
- Nova Scotia Cancer Care Program
- Date of Publication
- 2018
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Antineoplastic Agents - adverse effects
- Blood Coagulation Disorders
- Drug-Related Side Effects and Adverse Reactions
- Hematologic Diseases
- Self Care
- Thrombocytopenia
- Subjects (LCSH)
- Antineoplastic agents--Side effects
- Blood cells--Diseases
- Blood coagulation disorders
- Cancer--Chemotherapy--Complications
- Self-care, Health
- Thrombocytopenia
- Specialty
- Hematology
- Abstract
- Platelets (PLT), thrombocytes, are blood cells that helps it to clot (stop bleeding). Not having enough platelets in your blood is called thrombocytopenia (throm·bo·cy·to·pe·nia). This pamphlets describes what causes low platelets, symptoms, and ways to prevent and manage it.
- Notes
- Patient & family guide
- Responsibility
- prepared by Nova Scotia Cancer Care Program
- Pamphlet Number
- 0032
